Jenburkt Pharma (524731)
STALWARTScore breakdown: P/E: 2/3 · ROCE: 2/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹865.75 |
| Market Cap | ₹386.6 Cr |
| P/E Ratio | 13.67 |
| ROCE | 27.18% |
| ROE | 20.55% |
| Dividend Yield | 1.79% |
| Profit Growth | -8.91% |
| Debt/Equity | — |
| Sales Growth | 16.62% |
| 52-Week Range | ₹944 — ₹1,410 |
| Sector | Pharmaceuticals & Biotechnology |
| Book Value | ₹354.77 |
Jenburkt Pharma trades with a P/E ratio of 13.67, ROCE of 27.18%, ROE of 20.55%, profit growth of -8.91%.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer